Atherosclerosis and restenosis: reflections on the Lovastatin Restenosis Trial and Scandinavian Simvastatin Survival Study.
Atherosclerosis is related to serum lipids, whereas restenosis after coronary angioplasty is probably not, reflecting different pathophysiologies. Nonetheless, treatment of lipid disorders is appropriate after angioplasty.
W S
WS
Weintraub
J P
JP
Pederson
D015906:Angioplasty, Balloon, Coronary; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D003324:Coronary Artery Disease / Q000097:blood / Q000150:complications / Q000401:mortality / Q000517:prevention & control*; D016757:Death, Sudden, Cardiac / Q000517:prevention & control; D006801:Humans; D008148:Lovastatin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000517:prevention & control; D017035:Pravastatin / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D012537:Scandinavian and Nordic Countries; D019821:Simvastatin; D016019:Survival Analysis
D000924:Anticholesteremic Agents; D008148:Lovastatin; D019821:Simvastatin; D017035:Pravastatin